BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dewanjee S, Vallamkondu J, Kalra RS, Chakraborty P, Gangopadhyay M, Sahu R, Medala V, John A, Reddy PH, De Feo V, Kandimalla R. The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus. Cells 2021;10:1340. [PMID: 34071497 DOI: 10.3390/cells10061340] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Molinari S, Imbriano C, Moresi V, Renzini A, Belluti S, Lozanoska-ochser B, Gigli G, Cedola A. Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism. Front Mol Biosci 2023;10. [DOI: 10.3389/fmolb.2023.1130183] [Reference Citation Analysis]
2 Flores A, Moyano P, Sola E, García JM, García J, Anadon MJ, Frejo MT, Naval MV, Fernadez MDLC, Pino JD. Single and repeated bisphenol A treatment induces ROS, Aβ and hyperphosphorylated-tau accumulation, and insulin pathways disruption, through HDAC2 and PTP1B overexpression, leading to SN56 cholinergic apoptotic cell death. Food and Chemical Toxicology 2022;170:113500. [DOI: 10.1016/j.fct.2022.113500] [Reference Citation Analysis]
3 Ramms B, Pollow DP, Zhu H, Nora C, Harrington AR, Omar I, Gordts PLSM, Wortham M, Sander M. Systemic LSD1 Inhibition Prevents Aberrant Remodeling of Metabolism in Obesity. Diabetes 2022;71:2513-29. [PMID: 36162056 DOI: 10.2337/db21-1131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Nagaya M, Yamaoka R, Kanada F, Sawa T, Takashima M, Takamura Y, Inatani M, Oki M. Histone acetyltransferase inhibition reverses opacity in rat galactose-induced cataract. PLoS One 2022;17:e0273868. [PMID: 36417410 DOI: 10.1371/journal.pone.0273868] [Reference Citation Analysis]
5 Sonthalia M, Roy BS, Chandrawanshi D, Ganesh GV, Jayasuriya R, Mohandas S, Rajagopal S, Ramkumar KM. Histone deacetylase inhibitors as antidiabetic agents: Advances and opportunities. European Journal of Pharmacology 2022;935:175328. [DOI: 10.1016/j.ejphar.2022.175328] [Reference Citation Analysis]
6 Chen H, Xie C, Chen Q, Zhuang S. HDAC11, an emerging therapeutic target for metabolic disorders. Front Endocrinol 2022;13:989305. [DOI: 10.3389/fendo.2022.989305] [Reference Citation Analysis]
7 Chang S, Tsai H, Kuo J, Ruan Y, Chen C, Wang S, Liu P, Lee D. Blood Reflux-Induced Epigenetic Factors HDACs and DNMTs Are Associated with the Development of Human Chronic Venous Disease. IJMS 2022;23:12536. [DOI: 10.3390/ijms232012536] [Reference Citation Analysis]
8 Yan A, Zhao Y, Zhang L, Liang X, Zhang X, Liang F, Nian S, Li X, Sun Z, Li K, Zhao YF. β-Hydroxybutyrate upregulates FGF21 expression through inhibition of histone deacetylases in hepatocytes. Open Life Sci 2022;17:856-64. [PMID: 36045720 DOI: 10.1515/biol-2022-0095] [Reference Citation Analysis]
9 Kumar A, Datta M. H19 inhibition increases HDAC6 and regulates IRS1 levels and insulin signaling in the skeletal muscle during diabetes. Mol Med 2022;28:81. [PMID: 35842608 DOI: 10.1186/s10020-022-00507-3] [Reference Citation Analysis]
10 Ramms B, Pollow DP, Zhu H, Nora C, Harrington AR, Omar I, Gordts PL, Wortham M, Sander M. Systemic LSD1 inhibition prevents aberrant remodeling of metabolism in obesity.. [DOI: 10.1101/2021.11.25.469928] [Reference Citation Analysis]
11 Zhang Y, Lei Y, Honarpisheh M, Kemter E, Wolf E, Seissler J. Butyrate and Class I Histone Deacetylase Inhibitors Promote Differentiation of Neonatal Porcine Islet Cells into Beta Cells. Cells 2021;10:3249. [PMID: 34831471 DOI: 10.3390/cells10113249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Ogunmokun G, Dewanjee S, Chakraborty P, Valupadas C, Chaudhary A, Kolli V, Anand U, Vallamkondu J, Goel P, Paluru HPR, Gill KD, Reddy PH, De Feo V, Kandimalla R. The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer's Disease. Cells 2021;10:2790. [PMID: 34685770 DOI: 10.3390/cells10102790] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
13 Sugita E, Hayashi K, Hishikawa A, Itoh H. Epigenetic Alterations in Podocytes in Diabetic Nephropathy. Front Pharmacol 2021;12:759299. [PMID: 34630127 DOI: 10.3389/fphar.2021.759299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]